Profilo
Kevin Harris is currently the Chief Commercial Officer at VectivBio Holding AG since 2019.
Prior to this, he worked at Incyte Corp.
for 10 years from 2009 to 2019, where he held the position of Group Vice President-Global Product Strategy from 2017 to 2019.
Mr. Harris completed his undergraduate degree at Cornell University and obtained an MBA from Kellogg School of Management.
Precedenti posizioni note di Kevin Harris
Società | Posizione | Fine |
---|---|---|
INCYTE CORPORATION | Corporate Officer/Principal | 01/10/2019 |
VECTIVBIO HOLDING AG | Corporate Officer/Principal | - |
Formazione di Kevin Harris
Kellogg School of Management | Masters Business Admin |
Cornell University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
INCYTE CORPORATION | Health Technology |
Aziende private | 1 |
---|---|
VectivBio Holding AG
VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Kevin Harris